Garrett Richards’ Bullpen Rebirth

The Red Sox’ offseason addition of right-hander Garrett Richards to their rotation didn’t pan out quite like chief baseball officer Chaim Bloom, general manager Brian O’Halloran and the rest of the Boston front office hoped. Richards got out to a solid start, pitching to a 3.75 ERA through his first 11 trips with a 20.2 percent strikeout rate, an 11.6 percent walk rate and a 48.9 percent ground-ball rate. Richards wasn’t exactly dominant, but for a pitcher who’d signed a one-year, $10MM contract with a club option, the results to that point were a bargain.

Things spiraled downhill rapidly for Richards from that point forth, however. Over his next 11 starts, from June 6 through Aug. 8, Richards was clobbered for a 6.97 ERA. He went from averaging just over 5 1/3 innings per start to 4 1/3 frames, and his strikeout rate plummeted to just 14.3 percent.

This isn’t intended to serve as some form of exposé on pitchers utilizing foreign substances, but it’s important context to note that Richards, a traditionally high-spin-rate pitcher, saw his decline coincide with the league’s memo on the forthcoming foreign-substance crackdown. Richards didn’t shy away from acknowledging that he’d used foreign substances, though he insisted to Jen McCaffrey of The Athletic that he’d only ever used a combination of sunscreen and rosin. (Both McCaffrey’s June 24 and June 30 interviews with Richards are well worth a full read for context.)

“(I’m) going through a little transition period right now,” Richards told McCaffery in late June. “Changing some grips on some of my pitches, learning new pitches, just trying to figure this whole thing out.”

That “transition” period didn’t exactly pay dividends for Richards, as evidenced by the previously referenced plummet in his results. The Red Sox gave him some runway to try to sort things out, but on Aug. 11, they pulled him from the rotation and plugged him into the bullpen. So far, it’s proven to be a game-changer for both the Sox and for Richards himself.

Since moving into a short-relief role, Richards has dominated. He’s tossed 20 2/3 innings of relief, pitching to a 0.87 ERA with a 29.4 percent strikeout rate, a 9.4 percent walk rate and a 48.1 percent ground-ball rate. Richards’ fastball averaged 94.2 mph out of the rotation, and that’s jumped to 95.0 mph in the ‘pen — 95.3 mph since Sept. 1.

Richards has also seen gains in swinging-strike rate (from 9.4 percent to 10.8 percent), opponents’ chase rate (27.9 percent to 34.5 percent), opponents’ average exit velocity (91.6 mph to 89.4 mph) and an overwhelming drop in his opponents’ barrel rate — from 9.3 percent all the way down to 1.9 percent. Since moving to a relief role, he’s allowed just one “barreled” ball, as measured by Statcast, and he has yet to surrender a home run.

It’s true that we’re only looking at a sample of 20 2/3 frames right now, but Richards’ dominance is going to give the Red Sox a decision that as recently as early August looked to be a foregone conclusion. The 33-year-old’s one-year, $10MM contract carries a $10MM club option for the 2022 season, which comes with a $1.5MM buyout. The Red Sox will effectively have to make a net $8.5MM decision on him for the 2022 season, and while that looked like an easy option to buy out when he was floundering in the rotation, the price tag suddenly looks much more palatable.

Some may raise an eyebrow at the notion of doling out an extra $8.5MM based on a few weeks of work in the bullpen, but there’s pretty recent precedent of a reliever being paid at that level following a similar late shift to the ‘pen. When the Brewers acquired Drew Pomeranz from the Giants in 2019, they did so by somewhat surprisingly sending a fairly well regarded prospect to San Francisco in return: Mauricio Dubon. Pomeranz had made just four relief appearances when the Brewers took that plunge.

It proved to be a terrific decision for Milwaukee, as Pomeranz worked to a 2.39 ERA with an overwhelming 45 percent strikeout rate in 26 1/3 innings down the stretch. He rode that wave of momentum into free agency, where he cashed in on a four-year, $34MM contract with the Padres.

Pomeranz was excellent through his first 44 1/3 innings of that contract before undergoing season-ending surgery, but the results of his contract aren’t really consequential with regard to Richards. The mere fact that Pomeranz was able to command a four-year deal in the first place certainly suggests that the market could bear a nice multi-year guarantee for Richards, assuming he sustains this pace for the season’s final couple of weeks. Richards hasn’t quite as dominant in terms of missing bats and limiting walks, and it’s critical to point out that he’s two years older now than Pomeranz was when he hit free agency. Still, even if a four-year pact isn’t on the table, a two- or three-year contract could be feasible.

The Sox have just shy of $104MM in guarantees on the books for next season. They’ll have to make decisions on club options for catcher Christian Vazquez ($7MM) and left-hander Martin Perez ($6MM). Boston also owes $16MM to the Dodgers under the David Price trade. Even with those additional financial considerations, this is a former luxury-tax payor who came close to paying the tax in 2021. Payrolls in the $200MM range aren’t out of the norm in Boston. A net $8.5MM decision on a reliever who has looked largely unhittable late since moving out of the rotation is something they can afford if they’re sold on Richards’ renaissance in the bullpen.

If the Sox ultimately decide to buy Richards out and pursue other bullpen options, that could work out even better for the right-hander. He’d suddenly be one of the more interesting options in a free-agent class of relievers that doesn’t feature many high-end names. Whatever path the Sox choose, the decision to move Richards out of the rotation looks like a good one for all parties at this point.

Red Sox Activate Chris Sale, Matt Barnes From Injured List

The Red Sox announced they’ve reinstated ace Chris Sale and closer Matt Barnes from the COVID-19 injured list. Ryan Brasier was optioned to Triple-A Worcester, while Michael Feliz was designated for assignment to clear roster space.

Sale and Barnes become the two latest players to return after testing positive for the coronavirus. The Sox are still without Christian ArroyoYairo MuñozJarren DuranJonathan AraúzDanny Santana and Phillips Valdéz for virus-related reasons. Sale and Barnes were perhaps the two most impactful players yet to return from the outbreak before this evening, though.

After missing all of 2020 and a good portion of 2021 recovering from Tommy John surgery, Sale returned to make five starts before testing positive on September 9. He turned in a few vintage performances before contracting the virus, working 25 innings of 2.52 ERA ball with a quality 27.5% strikeout percentage and a tiny 5.5% walk rate. Getting a few more great starts down the stretch would be critical for a Boston team that enters play tonight tied with the Blue Jays and holding a half-game advantage over the archrival Yankees for the American League’s two Wild Card spots.

Barnes missed a bit more time than Sale did, as he tested positive on August 30. That couple weeks on the shelf required him to make a pair of minor league rehab appearances this week before returning to the active roster. One of the league’s best relievers in the first half, Barnes had a disastrous August and will be looking to return to his early-season form down the stretch.

The Red Sox signed Feliz to a minor league deal near the end of August and selected him to the major league club a couple weeks later. He made just four appearances for Boston, tossing 5 1/3 frames of two-run ball before losing his spot. The Red Sox will place the 28-year-old on waivers over the next few days.

Feliz has split the 2021 season between three teams, pitching for the Pirates and Reds in addition to his work with the Sox. He’s posted a 7.32 ERA in 19 2/3 innings between that trio of clubs despite solid strikeout and walk rates (25.3% and 6.9%, respectively). Opposing hitters have popped four home runs off the fly-ball pitcher in that limited body of work.

Red Sox Release Brandon Brennan

The Red Sox have released reliever Brandon Brennan, reports Alex Speier of the Boston Globe (Twitter link). He’d been with Triple-A Worcester after passing through outright waivers a couple months ago.

A Rule 5 draftee of the Mariners over the 2018-19 offseason, Brennan was a frequently-used bullpen option in Seattle in 2019. That year, he tossed 47 1/3 innings of 4.56 ERA ball, issuing a few too many walks but missing a fair amount of bats and racking up ground-balls at a 55.2% rate. The right-hander missed most of last season due to a severe oblique strain, though, and Seattle designated him for assignment this April.

The Red Sox claimed Brennan off waivers, but he’d only make one appearance with the big league club. He tossed three innings of scoreless relief but was designated for assignment the following night when Boston needed a fresh arm. Otherwise, Brennan has spent the year with Worcester, tossing 37 2/3 frames of relief for the WooSox. He’s only managed a 5.97 ERA, but his strikeout and walk rates (21.4% and 8.7%, respectively) weren’t far off the league average.

Brennan was plagued by opponents’ elevated .363 batting average on balls in play in Worcester and probably didn’t pitch as poorly as that run prevention mark would indicate. Nevertheless, he’d clearly fallen down the organizational depth chart, as the front office called upon other hurlers to come up in recent weeks while the big league pitching staff dealt with a series of COVID-19 related absences. Brennan will now be free to sign elsewhere, and it wouldn’t be surprising to see another club add the 30-year-old on a minor league deal to bolster their bullpen depth.

Red Sox Activate Martin Perez

SEPTEMBER 14: As expected, Boston reinstated Pérez from the injured list before Tuesday’s game against the Mariners. To create roster space, righty Kaleb Ort has been removed from the active and 40-man rosters and returned to Worcester.

SEPTEMBER 13: The Red Sox have activated reliever Hirokazu Sawamura from the COVID-19 injured list. Fellow reliever Austin Davis is also back from paternity leave. In corresponding moves, Brad Peacock and Stephen Gonsalves were returned to Triple-A Worcester. Peacock and Gonsalves had each been selected to the roster as COVID replacements, so they can be removed from the active and 40-man rosters without being exposed to waivers. Additionally, right-hander Eduard Bazardo has been reinstated from the 60-day injured list and optioned to Worcester.

Sawamura has been out since August 31 after testing positive for the virus as part of the spread throughout the Sox’s clubhouse. Signed to a two-year deal over the offseason after a nine-year career in Japan’s Nippon Professional Baseball, Sawamura has a 3.09 ERA over 46 2/3 innings during his first MLB season. The 33-year-old has shown some worrying control issues, walking 14.2% of opposing hitters, but he’s also punched out an above-average 26.5% of batters faced.

Peacock has made two appearances (including one start) since being acquired from the Indians and called up in the early stages of the outbreak. He has allowed nine runs in 5 1/3 innings. Gonsalves, meanwhile, has worked 4 1/3 innings of two-run ball in relief, his first big league action since he tossed 24 2/3 frames as a rookie with the 2018 Twins.

Manager Alex Cora provided updates on a few more players on the COVID IL (via Chris Cotillo of MassLive and Pete Abraham of the Boston Globe). Lefty Martín Pérez is expected to make it back tomorrow, while closer Matt Barnes will make a couple minor league rehab appearances and is expected to return to the big league club this weekend. The team hopes that ace Chris Sale, who tested positive on September 9, will make it back to start a game against the Orioles this weekend.

COVID Notes: 9/12/21

The latest updates on coronavirus situations around baseball…

Latest Moves

  • The Red Sox placed yet another player on the COVID list, as right-hander Phillips Valdez tested positive for the virus (MassLive.com’s Chris Cotillo was among those to report the news.)  Right-hander Brad Peacock will join the active roster in Valdez’s place after Peacock’s contract was selected from Triple-A Worcester.  Between Pivetta’s activation and Valdez joining, Boston’s COVID list remains at 10 players.

Earlier Today

  • The Red Sox reinstated right-hander Nick Pivetta from the COVID-related injury list today, and optioned righty Connor Seabold to Triple-A.  Pivetta will get the start today against the White Sox after recovering from a case of COVID-19 that sidelined him on September 5.  (As per league regulations, Pivetta was cleared to return after seven days because he was fully vaccinated earlier this season.)  It has been something of an up-and-down season for Pivetta, and the righty is looking to bounce back after posting a 10.13 ERA over 10 2/3 innings pitched in his last three starts.

Red Sox Place Danny Santana On COVID List, Select Jack Lopez

Just four days after Danny Santana was reinstated from the COVID-related injury list, the Red Sox have sent the utilityman back to the COVID-IL.  Infielder Jack Lopez has had his contract selected from Triple-A, and Lopez will take Santana’s spot on the active roster.

Santana has tested positive for COVID-19, MLB.com’s Ian Browne reports (via Twitter), so he will miss at least 10 days while quarantined.  Santana previously spent only two days on the COVID-IL due to symptoms, rather than any positive tests.  He now becomes the latest Red Sox player to test positive in what has been a long-lasting outbreak within the Boston clubhouse.  While some players have started to return to action, Santana is the tenth Sox player currently on the team’s COVID list.

After an elbow injury limited Santana to 15 games with the Rangers in 2020, health issues have again plagued the utilityman in his first season in Boston.  Between a foot infection, a left quad strain, a left groin strain, and his two COVID-IL stints, Santana has appeared in just 38 games for the Red Sox, and batted only .181/.252/.345 in 127 plate appearances.  Santana’s minor league contract became a guaranteed deal worth $1.75MM when he made the big league roster, though a reunion between Santana and the Sox doesn’t seem very likely in 2022.

This is the second time Lopez has been selected to Boston’s roster in the midst of this coronavirus outbreak, resulting in the 28-year-old getting to make his Major League debut after nine seasons in the minors.  A 16th-round pick for the Royals in the 2011 draft, Lopez has spent much of his career in Kansas City’s farm system before moving to the Braves’ organization in 2019 and then signing with the Sox this past offseason.  Lopez hit .167/.231/.333 in his first 15 PA as a big leaguer.

Red Sox’ Connor Seabold To Make Major League Debut

2:50 pm: Brad Peacock has been returned to Triple-A as the corresponding roster move, per Cotillo (via Twitter). Peacock made two appearances, allowing nine runs in 5 1/3 innings.

11:09 am: Right-hander Connor Seabold will be added to the Red Sox active roster to make his first career start tonight against the White Sox, per Chris Cotillo of Masslive.com (via Twitter).

Seabold will start in place of Nick Pivetta, who is on the COVID-related injured list. Seabold and Pivetta came to Boston together in a trade with the Phillies last August. The deal sent relievers Heath Hembree and Brandon Workman to Philadelphia – neither of whom remain with the team.

The 25-year-old Seabold was Boston’s 8th-ranked prospect by Fangraphs at the start of this season. He is their 12th-ranked prospect by Baseball America, who wrote in their scouting report, “Seabold’s three-pitch mix includes a 90-93 mph fastball that sometimes ticks up slightly higher, an excellent changeup with sink and fade and a below-average slider that plays up because of command and deception.”

The Red Sox currently hold the top wild card spot, but their grip is loose. The Yankees trail by just a half game, while the Blue Jays, Athletics, and Mariners are all within a game of New York. Seabold will be thrown right into the fire as the Red Sox continue to deal with a long list of positive COVID-19 tests.

Red Sox Select Kaleb Ort

The Red Sox announced a series of roster moves before this evening’s game against the White Sox. As expected, shortstop Xander Bogaerts has been reinstated from the COVID-19 injured list. Hard-throwing reliever Darwinzon Hernández has been activated from the 10-day IL, while the club selected fellow bullpen arm Kaleb Ort. In corresponding moves, starter Chris Sale was placed on the COVID-19 IL after testing positive for the virus and reliever Austin Davis was placed on the paternity list. Additionally, infielder Jonathan Araúz has been placed on the COVID IL. He’s experiencing virus-like symptoms but has continued to test negative, relays Chris Cotillo of MassLive (Twitter link).

Ort is up to make his major league debut. The right-hander went undrafted out of Aquinas College in 2016. He signed with the Diamondbacks but was released not long after and then latched on with the Yankees. Ort spent the past few seasons in the New York system, but the Red Sox added him in the minor league phase of last offseason’s Rule 5 draft.

Assigned to Worcester, Ort has pitched well at the minors’ top level to earn the call. The 29-year-old has worked 43 1/3 innings of 3.12 ERA ball with the WooSox, striking out a very strong 30.4% of batters faced. Ort has had issues with his control throughout his pro career, but his 10.3% walk rate this season is only marginally above the league average for relievers.

Hernández is back after missing a little more than five weeks with a right oblique strain. The southpaw has a 3.44 ERA in 34 frames of relief despite an elevated 16.9% walk percentage. That’s largely thanks to his quality 29.9% strikeout rate, a continuation of Hernández’s lofty punch out and walk totals throughout his big league career.

Red Sox To Activate Xander Bogaerts From Injured List

The Red Sox are planning to activate star shortstop Xander Bogaerts from the COVID-19 injured list before this evening’s game against the White Sox, reports Chris Cotillo of MassLive (Twitter link). He has been out since testing positive for the virus on August 31.

Boston has held their own in Bogaerts’ absence, going 5-4 over that nine-game stretch. Bogaerts was one of ten Red Sox players to test positive as the virus has spread throughout the clubhouse. While he and Kiké Hernández have now made it back to action, a good portion of the roster remains on the virus-related IL. Indeed, that spread continued to impact the club as recently as this afternoon, when it was announced that ace Chris Sale tested positive.

Bogaerts is arguably the most important player the Red Sox were without during their outbreak. The three-time All-Star has a fantastic .298/.366/.501 line over 519 plate appearances this season, making him one of the more valuable position players in the league. He returns at a time when the Sox hold a one-game advantage over the Yankees for the American League’s top Wild Card spot, with the Blue Jays just half a game behind New York.

Red Sox Outright Taylor Motter

Sept. 10: Motter was not claimed on waivers and has been assigned outright to Triple-A Worcester, the Red Sox announced Friday

Sept. 7: The Red Sox announced a series of roster moves before this evening’s game against the Rays. Utilitymen Kiké Hernández and Danny Santana were both reinstated from the COVID-19 injured list. To open active roster space, outfielder Franchy Cordero was optioned to Triple-A Worcester while infielder Taylor Motter was designated for assignment.

Hernández was the first player on the Red Sox to test positive amidst the recent viral spread that has affected a sizable chunk of the roster. He’s also the first player to return from that group, and he’ll take his customary place atop the lineup this evening. Signed over the offseason to a two-year deal, Hernández has put together one of the better seasons of his career in his first year in Boston. The 30-year-old owns a .258/.346/.465 line over 483 plate appearances.

Motter was claimed off waivers from the Rockies last Thursday to bolster the infield depth with Hernández, Santana, Xander Bogaerts and Yairo Muñoz all on the COVID IL. He’ll lose his roster spot after just three games with a couple of the original options returning. While internal players selected as COVID replacements can be bumped from the active and 40-man rosters without being made available to other teams, those acquired from outside the organization (like Motter) still need to stick on the 40-man or be exposed to waivers.

While Motter hasn’t gotten much of a big league look this season, he posted fantastic numbers with the Rockies’ top affiliate in Albuquerque. Over 265 plate appearances with the Isotopes, Motter hit .335/.460/.759 with 24 home runs and matching strikeout and walk rates (18.5%). That strong showing — coupled with his positional versatility — could pique the interest of another club once he lands on waivers.

While the Red Sox have begun to get some players back from the COVID IL, it wasn’t unanimously positive news on that front. Starting pitcher Nick Pivetta, who landed on the IL last Sunday, has tested positive for the virus, manager Alex Cora revealed to reporters (including Alex Speier of the Boston Globe). The positive test will keep another key player for Boston out of action for at least the next week-plus. The Red Sox enter play tonight holding a three-game advantage over the Blue Jays and Mariners in the American League Wild Card race.

Show all